Total Payments
$17,086
2024 Payments
$2,000
Companies
24
Transactions
347
Medicare Patients
1,617
Medicare Billing
$250,515
Payment Breakdown by Category
Other$10,062 (58.9%)
Food & Beverage$6,860 (40.1%)
Education$106.10 (0.6%)
Travel$58.00 (0.3%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $10,063 | 9 | 58.9% |
| Food and Beverage | $6,860 | 334 | 40.1% |
| Education | $106.10 | 3 | 0.6% |
| Travel and Lodging | $58.00 | 1 | 0.3% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Sunovion Pharmaceuticals Inc. | $7,200 | 40 | $0 (2022) |
| Otsuka America Pharmaceutical, Inc. | $4,199 | 10 | $0 (2023) |
| ABBVIE INC. | $1,161 | 73 | $0 (2024) |
| ITI, Inc. | $786.90 | 43 | $0 (2023) |
| Axsome Therapeutics, Inc. | $536.03 | 31 | $0 (2024) |
| Teva Pharmaceuticals USA, Inc. | $502.65 | 17 | $0 (2024) |
| Allergan, Inc. | $328.90 | 25 | $0 (2020) |
| Tris Pharma Inc | $251.58 | 11 | $0 (2024) |
| Supernus Pharmaceuticals, Inc. | $222.24 | 32 | $0 (2023) |
| Neurocrine Biosciences, Inc. | $213.07 | 2 | $0 (2022) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $2,000 | 83 | ABBVIE INC. ($534.52) |
| 2023 | $1,538 | 113 | ITI, Inc. ($435.69) |
| 2022 | $5,001 | 42 | Otsuka America Pharmaceutical, Inc. ($4,102) |
| 2021 | $396.17 | 22 | ITI, Inc. ($159.02) |
| 2020 | $208.33 | 13 | Allergan, Inc. ($83.54) |
| 2019 | $6,818 | 34 | Sunovion Pharmaceuticals Inc. ($6,488) |
| 2018 | $617.18 | 30 | Sunovion Pharmaceuticals Inc. ($434.31) |
| 2017 | $507.62 | 10 | Neos Therapeutics, LP ($206.10) |
All Payment Transactions
347 individual payment records from CMS Open Payments — Page 1 of 14
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/12/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $19.88 | General |
| Category: NEUROSCIENCE | ||||||
| 12/11/2024 | Teva Pharmaceuticals USA, Inc. | UZEDY (Drug) | Food and Beverage | In-kind items and services | $4.77 | General |
| Category: Neurology | ||||||
| 12/04/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $6.69 | General |
| Category: NEUROSCIENCE | ||||||
| 12/02/2024 | Axsome Therapeutics, Inc. | Auvelity (Drug) | Food and Beverage | In-kind items and services | $19.70 | General |
| Category: Psychology/Psychiatric | ||||||
| 11/21/2024 | Tris Pharma Inc | Dyanavel XR (Drug) | Food and Beverage | In-kind items and services | $23.30 | General |
| Category: ADHD | ||||||
| 11/21/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $6.63 | General |
| Category: NEUROSCIENCE | ||||||
| 11/14/2024 | Teva Pharmaceuticals USA, Inc. | UZEDY (Drug) | Food and Beverage | In-kind items and services | $119.70 | General |
| Category: Neurology | ||||||
| 11/13/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $19.91 | General |
| Category: NEUROSCIENCE | ||||||
| 11/12/2024 | Tris Pharma Inc | Dyanavel XR (Drug), Quillivant, Quillichew ER | Food and Beverage | In-kind items and services | $124.74 | General |
| Category: ADHD | ||||||
| 11/04/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $24.21 | General |
| Category: NEUROSCIENCE | ||||||
| 10/30/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $15.40 | General |
| Category: NEUROSCIENCE | ||||||
| 10/29/2024 | Tris Pharma Inc | Dyanavel XR (Drug) | Food and Beverage | In-kind items and services | $11.42 | General |
| Category: ADHD | ||||||
| 10/24/2024 | Axsome Therapeutics, Inc. | Auvelity (Drug) | Food and Beverage | In-kind items and services | $102.45 | General |
| Category: Psychology/Psychiatric | ||||||
| 10/23/2024 | Axsome Therapeutics, Inc. | Auvelity (Drug) | Food and Beverage | In-kind items and services | $20.59 | General |
| Category: Psychology/Psychiatric | ||||||
| 10/18/2024 | Axsome Therapeutics, Inc. | Auvelity (Drug) | Food and Beverage | In-kind items and services | $2.60 | General |
| Category: Psychology/Psychiatric | ||||||
| 10/11/2024 | E.R. Squibb & Sons, L.L.C. | COBENFY (Drug) | Education | In-kind items and services | $27.27 | General |
| Category: Psychiatry/Psychology | ||||||
| 10/10/2024 | E.R. Squibb & Sons, L.L.C. | — | Food and Beverage | Cash or cash equivalent | $106.74 | General |
| 10/08/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $6.84 | General |
| Category: NEUROSCIENCE | ||||||
| 10/03/2024 | Vanda Pharmaceuticals Inc. | FANAPT (Drug) | Food and Beverage | In-kind items and services | $20.84 | General |
| Category: SCHIZOPHRENIA | ||||||
| 10/01/2024 | Teva Pharmaceuticals USA, Inc. | UZEDY (Drug) | Food and Beverage | In-kind items and services | $4.88 | General |
| Category: Neurology | ||||||
| 09/30/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $31.65 | General |
| Category: NEUROSCIENCE | ||||||
| 09/20/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $13.01 | General |
| Category: NEUROSCIENCE | ||||||
| 09/18/2024 | Tris Pharma Inc | Dyanavel XR (Drug) | Food and Beverage | In-kind items and services | $9.67 | General |
| Category: ADHD | ||||||
| 09/18/2024 | Tris Pharma Inc | Dyanavel XR (Drug) | Food and Beverage | In-kind items and services | $2.19 | General |
| Category: ADHD | ||||||
| 09/05/2024 | Vanda Pharmaceuticals Inc. | FANAPT (Drug) | Food and Beverage | In-kind items and services | $21.47 | General |
| Category: SCHIZOPHRENIA | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 6 | 505 | 1,220 | $172,874 | $64,872 |
| 2022 | 5 | 372 | 1,100 | $154,885 | $66,230 |
| 2021 | 5 | 387 | 1,113 | $153,010 | $65,860 |
| 2020 | 4 | 353 | 1,098 | $151,115 | $53,552 |
Total Patients
1,617
Total Services
4,531
Medicare Billing
$250,515
Procedure Codes
20
All Medicare Procedures & Services
20 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 187 | 586 | $76,180 | $30,422 | 39.9% |
| 90833 | Psychotherapy with evaluation and management visit, 30 minutes | Office | 2023 | 135 | 342 | $48,809 | $16,819 | 34.5% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 99 | 181 | $36,200 | $14,279 | 39.4% |
| 99442 | Telephone medical discussion with physician, 11-20 minutes | Office | 2023 | 55 | 80 | $10,400 | $2,945 | 28.3% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2023 | 12 | 13 | $1,105 | $359.69 | 32.6% |
| 96127 | Assessment of emotional or behavioral problems | Office | 2023 | 17 | 18 | $180.00 | $48.60 | 27.0% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 160 | 549 | $71,370 | $31,537 | 44.2% |
| 99442 | Telephone medical discussion with physician, 11-20 minutes | Office | 2022 | 118 | 399 | $51,870 | $21,920 | 42.3% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 62 | 119 | $23,800 | $10,123 | 42.5% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2022 | 14 | 14 | $6,230 | $1,992 | 32.0% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2022 | 18 | 19 | $1,615 | $657.97 | 40.7% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 231 | 909 | $118,170 | $51,139 | 43.3% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 57 | 88 | $17,600 | $7,108 | 40.4% |
| 99442 | Physician telephone patient service, 11-20 minutes of medical discussion | Office | 2021 | 59 | 68 | $8,840 | $4,564 | 51.6% |
| 99205 | New patient outpatient visit, total time 60-74 minutes | Office | 2021 | 12 | 12 | $5,340 | $1,939 | 36.3% |
| 99212 | Established patient outpatient visit, total time 10-19 minutes | Office | 2021 | 28 | 36 | $3,060 | $1,111 | 36.3% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 235 | 915 | $118,950 | $42,546 | 35.8% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 59 | 110 | $22,000 | $7,924 | 36.0% |
| 99205 | New patient office or other outpatient visit, typically 60 minutes | Office | 2020 | 11 | 11 | $4,895 | $1,629 | 33.3% |
| 99212 | Established patient office or other outpatient visit, typically 10 minutes | Office | 2020 | 48 | 62 | $5,270 | $1,453 | 27.6% |
About Dr. David Meyer, MD
Dr. David Meyer, MD is a Psychiatry healthcare provider based in Paducah, Kentucky. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 03/27/2006. The National Provider Identifier (NPI) number assigned to this provider is 1811957459.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. David Meyer, MD has received a total of $17,086 in payments from pharmaceutical and medical device companies, with $2,000 received in 2024. These payments were reported across 347 transactions from 24 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($10,063).
As a Medicare-enrolled provider, Meyer has provided services to 1,617 Medicare beneficiaries, totaling 4,531 services with total Medicare billing of $250,515. Data is available for 4 years (2020–2023), covering 20 distinct procedure/service records.
Ad
Practice Information
- Specialty Psychiatry
- Location Paducah, KY
- Active Since 03/27/2006
- Last Updated 07/22/2008
- Taxonomy Code 2084P0800X
- Entity Type Individual
- NPI Number 1811957459
Products in Payments
- LATUDA (Drug) $7,200
- REXULTI (Drug) $4,353
- VRAYLAR (Drug) $1,490
- CAPLYTA (Drug) $844.00
- Auvelity (Drug) $522.17
- UZEDY (Drug) $275.55
- Dyanavel XR (Drug) $251.58
- QELBREE (Drug) $222.24
- INGREZZA (Drug) $213.07
- Adzenys XR-ODT (Drug) $206.10
- FANAPT (Drug) $189.21
- ABILIFY MAINTENA (Drug) $163.57
- Austedo XR (Drug) $161.60
- TRINTELLIX (Drug) $140.42
- LYBALVI (Drug) $132.57
- SPRAVATO (Drug) $127.32
- QUVIVIQ (Drug) $117.95
- AUSTEDO (Drug) $65.50
- ARISTADA (Drug) $60.49
- XYWAV (Drug) $44.30
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Psychiatry Doctors in Paducah
Ronald Kelley, M.d, M.D
Psychiatry — Payments: $4,017
Psychiatry $4,017
Dr. Daniel Sussman, M.d, M.D
Psychiatry — Payments: $3,355
Psychiatry $3,355
Dr. Laurie Ballew, D.o, D.O
Psychiatry — Payments: $2,762
Psychiatry $2,762
Dr. Eugene Owsley, Md, MD
Psychiatry — Payments: $571.98
Psychiatry $571.98
Dr. Patrick Burba, M.d, M.D
Psychiatry — Payments: $80.97
Psychiatry $80.97
Robert Howard, M.d, M.D
Psychiatry — Payments: $15.24
Psychiatry $15.24